Valproic acid
aka - valproate
Valproic acid, first made in 1881 used since 1962, is primarily known for its use as an anticonvulsant and mood-stabilizing drug, and has recently garnered attention in the field of dermatology for its potential effects on hair growth and alopecia treatment. Scientifically, valproic acid operates by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, but its effects on hair growth are thought to be mediated through different pathways, possibly involving the inhibition of histone deacetylases (HDAC) which can influence gene expression beneficial for hair follicle health and activity.
Research has highlighted valproic acid's capacity to induce hair regeneration in both animal models and human dermal papilla cells by activating alkaline phosphatase activity—an enzyme associated with hair growth and follicle development. Studies indicate that valproic acid can promote hair growth by elongating the hair shaft and delaying the transition to the catagen (regression) phase, alongside promoting the anagen (growth) phase in vivo, providing a promising avenue for alopecia treatment.
The community's engagement with valproic acid reflects a keen interest in its utility for hair loss, with discussions often revolving around personal experiences and the exploration of valproic acid as a novel treatment. Community members share anecdotal evidence of its efficacy, particularly when used topically, noting improvements in hair density and growth. However, experiences vary, and while some individuals report positive outcomes, others call for more extensive research to conclusively determine its effectiveness and optimal application methods.
In summary, valproic acid presents a promising, albeit still under-researched, option for treating alopecia by potentially enhancing hair growth and follicle health through mechanisms distinct from its neurological effects. While initial research and community experiences offer hope, the call for further scientific investigation is clear to fully establish valproic acid's role in hair loss therapy.
Research
20 / 502 results
research The Effects of Biotin Supplementation on Alopecia in Rats Treated with Valproic Acid
research Valproate-Induced Change in Hair Color
research Difficult-To-Treat Idiopathic Generalized Epilepsy In A Young Woman
research Valproate-Associated Transaminitis and Rhabdomyolysis
research Valproate, Acetylcarnitine, Folic Acid, and Vitamin B12 in Spinal Muscular Atrophy: Preliminary Data of an Open-Label Study in Children
research Effect of Antiandrogens on Valproic Acid-Induced Neurodevelopmental Changes in Rats
research Histone Deacetylase Inhibitors Promote Neurosteroid-Mediated Cell Differentiation and Enhance Serotonin-Stimulated Brain-Derived Neurotrophic Factor Gene Expression in Rat C6 Glioma Cells
research Cosmetic Effects of Anti-Epileptic Drugs (AEDs)
research Sodium Valproate Improves Skin Flap Survival via Gamma-Aminobutyric Acid and Histone Deacetylase Inhibitory System
research Investigating the Synergic Effects of Valproic Acid and Crocin on BDNF and GDNF Expression in Epidermal Neural Crest Stem Cells
research Hair Loss in Psychopharmacology
research Dissolving Microneedles: Applications and Growing Therapeutic Potential
research Combined Drug Triads for Synergistic Neuroprotection in Retinal Degeneration
research Sex Differences in Animal Models of Sodium Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence
research Valproic Acid-Induced Cutaneous Leukocytoclastic Vasculitis
research Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis
research Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
research A Case of Androgenetic Alopecia Treated with Valproic Acid
research Anticonvulsant-Induced Cutaneous Reactions